SCS-3728327-7/10002/1

ASTRAZENECA — FEI 3020813206

Refusal Details

Date
September 16, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
118,3280